Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 3
2010 1
2011 1
2012 8
2013 5
2014 1
2015 2
2019 2
2020 3
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
Medicare Spending on Drugs With Accelerated Approval.
Ballreich J, Socal M, Bennett CL, Schoen MW, Trujillo A, Xuan A, Anderson G. Ballreich J, et al. Ann Intern Med. 2022 Jul;175(7):938-944. doi: 10.7326/M21-4442. Epub 2022 May 24. Ann Intern Med. 2022. PMID: 35605235
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).
Bennett CL, Hoque S, Olivieri N, Taylor MA, Aboulafia D, Lubaczewski C, Bennett AC, Vemula J, Schooley B, Witherspoon BJ, Godwin AC, Ray PS, Yarnold PR, Ausdenmoore HC, Fishman M, Herring G, Ventrone A, Aldaco J, Hrushesky WJ, Restaino J, Thomsen HS, Yarnold PR, Marx R, Migliorati C, Ruggiero S, Nabhan C, Carson KR, McKoy JM, Yang YT, Schoen MW, Knopf K, Martin L, Sartor O, Rosen S, Smith WK. Bennett CL, et al. EClinicalMedicine. 2020 Dec 23;31:100693. doi: 10.1016/j.eclinm.2020.100693. eCollection 2021 Jan. EClinicalMedicine. 2020. PMID: 33554084 Free PMC article.
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
Hoque S, Chen BJ, Schoen MW, Carson KR, Keller J, Witherspoon BJ, Knopf KB, Yang YT, Schooley B, Nabhan C, Sartor O, Yarnold PR, Ray P, Bobolts L, Hrushesky WJ, Dickson M, Bennett CL. Hoque S, et al. PLoS One. 2020 Jun 25;15(6):e0234541. doi: 10.1371/journal.pone.0234541. eCollection 2020. PLoS One. 2020. PMID: 32584835 Free PMC article.
Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program.
Jimenez J, Gwillim EC, Kosche C, Figueiredo A, Rauck C, Rangel SM, Choi J, West DP, Nardone B, Lacouture ME. Jimenez J, et al. J Am Acad Dermatol. 2020 Sep;83(3):955-957. doi: 10.1016/j.jaad.2020.01.059. Epub 2020 Jan 31. J Am Acad Dermatol. 2020. PMID: 32014533 Free PMC article. No abstract available.
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
Bennett CL, Schooley B, Taylor MA, Witherspoon BJ, Godwin A, Vemula J, Ausdenmoore HC, Sartor O, Yang YT, Armitage JO, Hrushesky WJ, Restaino J, Thomsen HS, Yarnold PR, Young T, Knopf KB, Chen B. Bennett CL, et al. PLoS One. 2019 Jul 31;14(7):e0219521. doi: 10.1371/journal.pone.0219521. eCollection 2019. PLoS One. 2019. PMID: 31365527 Free PMC article.
30 results